When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

"Disappointing" trial results, but some researchers remain hopeful ...

In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...

News headlines often compress complex science into a simple storyline: If two things are happening at the same time, one must ...

A peer navigator intervention following a nonfatal opioid overdose in the emergency department does not significantly reduce ...

Agency staff "strongly recommended" a sham surgery-controlled trial be conducted before an approval filing, a stance one ...

Well, good morning, everybody, and thank you once again for joining us for the 46th Annual TD Cowen Healthcare Conference. I'm Yaron Werber from the biotech team, and it's a great pleasure to moderate ...

The University of Warwick, which is setting up the Registry, plans to collect data for analysis from 500 AML patients at sites in 30 large metropolitan NHS hospitals across the UK by the end of this ...

A key advantage of using RWD in a natural history study is gaining diverse and representative data. RWD covers broad patient populations, including those with comorbidities, various age groups, and ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

TD Cowen 46th Annual Health Care Conference March 2, 2026 2:30 PM ESTCompany ParticipantsDave Gancarz - Chief Business ...

Transcript: Rare Diseases ...